Analisis Manajemen Tatalaksana Kanker Ginekologi di RSUP Sanglah di Era Pandemi COVID-19
Abstract
Pandemi COVID-19 memberikan tantangan tersendiri dalam penanganan kanker, khususnya kanker ginekologi. Kondisi pasien penderita kanker yang telah mengalami immunocompromised baik karena penyakitnya maupun efek samping dari obat-obatan yang diberikan, berpotensi meningkatkan risiko pasien kanker untuk mengalami infeksi COVID-19 berat. Penatalaksanaan utama dari kanker yang bertonggak pada tiga poros yaitu operasi, kemoterapi, dan radioterapi perlu dilakukan adaptasi demi meningkatkan angka survival rate pada pasien.
Management of Gynecological Cancers in the COVID-19 Era: a Persepctive from Sanglah General Hospital
Abstract
The COVID-19 pandemic as challenges in dealing with cancer, especially gynaecological cancer. The condition of cancer patients who have experienced immunocompromised due to both the disease and the side effects of the drugs increases the risk of cancer patients to experience severe COVID-19 infection. The management of cancer consists of three axes; surgery, chemotherapy, and radiotherapy, and needs to be adapted to increase patient survival.
Key word: COVID-19; chemotherapy; operative; radiotherapy; gynaecological cancer
Keywords
Full Text:
PDFReferences
Komite Penanganan COVID-19 dan Pemulihan Ekonomi Nasional. Situasi virus COVID-19 di Indonesia [Internet]. 2021 [cited 2021 Jan 24]. Available from: covid19.go.id
Akladios C, Azais H, Ballester M, Bendifallah S, Bolze P-A, Bourdel N, et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic-FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod. 2020;49(6):101729.
Anthony C, Ezugwu FO, Lawani OL. Challenges associated with the management of gynecological cancers in a tertiary hospital in South East Nigeria. Int J Womens Health. 2014;6:123–30.
Artha BP. Kanker Ginekologi dalam Masa Pandemi COVID-19 [Internet]. RSUP dr. Soeradji Tirtonegoro. 2020 [cited 2021 Feb 25]. Available from: https://rsupsoeradji.id/kanker-ginekologi-dalam-masa-pandemi-covid-19/
Pothuri B, Alvarez A, Armstrong DK, Chan J, Fader AN, Huh W, et al. Gynecologic Oncology Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis ☆. Gynecol Oncol [Internet]. 2020;(xxxx). Available from: https://doi.org/10.1016/j.ygyno.2020.04.694
Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, et al. Gynecologic Oncology Radiation therapy for gynecologic malignancies during the COVID-19 pandemic : International expert consensus recommendations. Gynecol Oncol [Internet]. 2020; Available from: https://doi.org/10.1016/j.ygyno.2020.06.486
Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Martin AG, et al. COVID-19 global pandemic: options for management of gynecologic cancers. BMJ Specialist Journals; 2020.
Fader AN, Huh WK, Kesterson J, Pothuri B, Wethington S, Wright JD, et al. When to operate, hesitate and reintegrate: society of gynecologic oncology surgical considerations during the COVID-19 pandemic. Gynecol Oncol. 2020;158(2):236–43.
DOI: http://dx.doi.org/10.24198/obgynia.v4i2s.274
Refbacks
- There are currently no refbacks.